Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2002American Journal of TransplantationOpen Access

Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYvon LebranchuAcadémie Nationale de MédecineFBFrank BridouxUniversité de PoitiersMBMatthias BüchlerUniversité de Tours

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lebranchu et al. (2002) studied this question.

synapsesocial.com/papers/6a271dc249ea0010ad416b35https://doi.org/10.1034/j.1600-6143.2002.020109.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS11997 · 130 citations
  2. 2Antilymphocyte Antibodies, Renal Transplantation, and Meta-Analysis1998 · 7 citations
  3. 3Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation1998 · 878 citations
  4. 4INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION12001 · 192 citations